Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1,180.00
-29.00 (-2.40%)
Mar 9, 2026, 5:24 PM IDT
TLV:REKA Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 137 | 151 | 169 | 176 | 266 | 306 | Upgrade
|
| Market Cap Growth | -14.60% | -10.35% | -3.96% | -33.89% | -13.13% | 34.20% | Upgrade
|
| Enterprise Value | 266 | 295 | 338 | 321 | 420 | 441 | Upgrade
|
| Last Close Price | 11.99 | 13.25 | 14.78 | 15.39 | 22.40 | 25.79 | Upgrade
|
| PE Ratio | - | 24.37 | - | - | 40.12 | 28.33 | Upgrade
|
| PS Ratio | 0.46 | 0.47 | 0.52 | 0.60 | 1.01 | 1.15 | Upgrade
|
| PB Ratio | 0.91 | 0.93 | 1.08 | 1.08 | 1.54 | 1.85 | Upgrade
|
| P/TBV Ratio | 1.47 | 1.50 | 1.90 | 1.39 | 1.90 | 1.90 | Upgrade
|
| P/FCF Ratio | 9.37 | 8.47 | 10.01 | 5.48 | 34.59 | - | Upgrade
|
| P/OCF Ratio | 6.52 | 5.70 | 5.95 | 4.50 | 12.55 | 27.11 | Upgrade
|
| EV/Sales Ratio | 0.89 | 0.92 | 1.05 | 1.10 | 1.59 | 1.66 | Upgrade
|
| EV/EBITDA Ratio | 92.51 | 17.05 | 13.00 | 7.87 | 11.73 | 10.86 | Upgrade
|
| EV/EBIT Ratio | - | - | 116.43 | 24.20 | 32.49 | 21.10 | Upgrade
|
| EV/FCF Ratio | 18.24 | 16.53 | 20.07 | 10.00 | 54.61 | - | Upgrade
|
| Debt / Equity Ratio | 0.90 | 0.83 | 1.18 | 1.02 | 0.96 | 1.00 | Upgrade
|
| Debt / EBITDA Ratio | 45.88 | 5.33 | 5.61 | 4.07 | 4.64 | 4.10 | Upgrade
|
| Debt / FCF Ratio | 9.28 | 7.52 | 10.89 | 5.17 | 21.59 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.86 | 0.79 | 1.06 | 0.90 | 0.85 | 0.78 | Upgrade
|
| Net Debt / EBITDA Ratio | -26.35 | 7.34 | 6.31 | 3.57 | 4.12 | 3.19 | Upgrade
|
| Net Debt / FCF Ratio | 8.87 | 7.12 | 9.74 | 4.53 | 19.16 | -17.61 | Upgrade
|
| Asset Turnover | 0.69 | 0.69 | 0.69 | 0.66 | 0.62 | 0.68 | Upgrade
|
| Inventory Turnover | 2.48 | 2.79 | 2.56 | 2.35 | 2.12 | 2.36 | Upgrade
|
| Quick Ratio | 0.90 | 0.90 | 1.01 | 1.06 | 1.30 | 1.17 | Upgrade
|
| Current Ratio | 1.65 | 1.45 | 1.75 | 1.75 | 2.25 | 2.10 | Upgrade
|
| Return on Equity (ROE) | -8.96% | 3.91% | -4.35% | -1.22% | 3.91% | 6.73% | Upgrade
|
| Return on Assets (ROA) | -4.04% | -0.98% | 0.39% | 1.87% | 1.88% | 3.32% | Upgrade
|
| Return on Invested Capital (ROIC) | -9.92% | -1.89% | 0.93% | -24.16% | 3.60% | 5.60% | Upgrade
|
| Return on Capital Employed (ROCE) | -9.80% | -2.50% | 0.90% | 4.30% | 3.80% | 6.70% | Upgrade
|
| Earnings Yield | -10.31% | 4.10% | -4.10% | -1.16% | 2.49% | 3.53% | Upgrade
|
| FCF Yield | 10.67% | 11.80% | 9.99% | 18.25% | 2.89% | -2.40% | Upgrade
|
| Dividend Yield | - | - | - | - | 3.87% | - | Upgrade
|
| Buyback Yield / Dilution | -4.25% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | -4.25% | - | - | - | 3.87% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.